Patricia Probeck-Quellec

Title: The Innovative Contributions of Patricia Probeck-Quellec in Immunology

Introduction: Patricia Probeck-Quellec, based in Lyons, France, is a distinguished inventor known for her significant contributions to the field of immunology. With two patents to her name, she has made remarkable strides in developing novel formulations aimed at improving vaccine efficacy and safety.

Latest Patents: Among her latest innovations are two notable patents. The first patent focuses on immunogenic formulations that incorporate linear or branched polyacrylic acid polymer adjuvants. This invention presents novel immunological and vaccine formulations featuring a non-crosslinked polyacrylic acid polymer adjuvant. These adjuvants can be combined with a variety of immunogens, including inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, and plasmids. The applications extend to multiple target animal species, such as humans, murine, canines, felines, equines, porcines, ovines, caprines, and bovines.

The second patent, described as an immuno-adjuvant emulsion, revolves around an oil-in-water adjuvant emulsion. This invention details a process for preparing an immunogenic composition by mixing a vaccine antigen with an oil-in-water emulsion obtained through a temperature-variation phase-inversion process. This innovative approach promises enhanced immunogenicity and potential health benefits across various animals.

Career Highlights: Throughout her career, Patricia has collaborated with leading firms in the pharmaceutical and veterinary sectors. Notably, she has worked with Sanofi Pasteur and Boehringer Ingelheim Animal Health USA Inc., companies renowned for their commitment to advancing health care through innovative solutions.

Collaborations: Patricia Probeck-Quellec has also been fortunate to work alongside accomplished colleagues, including Marie-Francoise Klucker and Francois Dalencon. These collaborations have contributed to her success and the impactful nature of her inventions, highlighting the importance of teamwork in the innovation process.

Conclusion: Patricia Probeck-Quellec's contributions to vaccine technology through her patented innovations serve as a critical advancement in the field of immunology. Her work not only showcases her inventiveness and dedication but also holds the potential to enhance animal and human health globally. As advancements in immunogenic formulations continue to evolve, her inventions remain a testament to the importance of innovation in the pursuit of safe and effective vaccines.